Journal: Ontario Health Technology Assessment Series

Article Title: Point-of-Care Hemoglobin A 1c Testing: An Evidence-Based Analysis

doi:

Figure Lengend Snippet: Manufacturer Information for POC HbA 1c Devices Licensed for Use in Canada

Article Snippet: They reported that at the time of writing, only 2 POC HbA 1c devices—DCA Vantage from Siemens and Afinion from Axis-Shield (not licensed by Health Canada)—met the criteria: that is, a coefficient of variation of < 3% and error criteria 1 of ± 0.85% as specified by the NGSP (in January 2010, the error criteria were lowered to ± 0.75%). ( 14 ) However, since experienced technologists at manufacturers’ sites performed the certification under ideal conditions, the results of this study may not reflect the performance of these devices in clinical settings.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Point-of-Care Hemoglobin A 1c Testing: An Evidence-Based Analysis

doi:

Figure Lengend Snippet: Characteristics of POC HbA 1c Devices Available for Use in Canada

Article Snippet: They reported that at the time of writing, only 2 POC HbA 1c devices—DCA Vantage from Siemens and Afinion from Axis-Shield (not licensed by Health Canada)—met the criteria: that is, a coefficient of variation of < 3% and error criteria 1 of ± 0.85% as specified by the NGSP (in January 2010, the error criteria were lowered to ± 0.75%). ( 14 ) However, since experienced technologists at manufacturers’ sites performed the certification under ideal conditions, the results of this study may not reflect the performance of these devices in clinical settings.

Techniques: Agglutination, Inhibition, Chromatography

Journal: Ontario Health Technology Assessment Series

Article Title: Point-of-Care Hemoglobin A 1c Testing: An Evidence-Based Analysis

doi:

Figure Lengend Snippet: Characteristics of Included Studies

Article Snippet: They reported that at the time of writing, only 2 POC HbA 1c devices—DCA Vantage from Siemens and Afinion from Axis-Shield (not licensed by Health Canada)—met the criteria: that is, a coefficient of variation of < 3% and error criteria 1 of ± 0.85% as specified by the NGSP (in January 2010, the error criteria were lowered to ± 0.75%). ( 14 ) However, since experienced technologists at manufacturers’ sites performed the certification under ideal conditions, the results of this study may not reflect the performance of these devices in clinical settings.

Techniques: High Performance Liquid Chromatography, Variant Assay

Journal: Ontario Health Technology Assessment Series

Article Title: Point-of-Care Hemoglobin A 1c Testing: An Evidence-Based Analysis

doi:

Figure Lengend Snippet: GRADE Evidence Profile for Comparison of POC HbA 1c and Lab HbA 1c

Article Snippet: They reported that at the time of writing, only 2 POC HbA 1c devices—DCA Vantage from Siemens and Afinion from Axis-Shield (not licensed by Health Canada)—met the criteria: that is, a coefficient of variation of < 3% and error criteria 1 of ± 0.85% as specified by the NGSP (in January 2010, the error criteria were lowered to ± 0.75%). ( 14 ) However, since experienced technologists at manufacturers’ sites performed the certification under ideal conditions, the results of this study may not reflect the performance of these devices in clinical settings.

Techniques: Comparison

Journal: Ontario Health Technology Assessment Series

Article Title: Point-of-Care Hemoglobin A 1c Testing: An Evidence-Based Analysis

doi:

Figure Lengend Snippet: Risk of Bias Among Observational Trials for the Comparison of POC HbA 1c and Lab HbA 1c (QUADAS-2)

Article Snippet: They reported that at the time of writing, only 2 POC HbA 1c devices—DCA Vantage from Siemens and Afinion from Axis-Shield (not licensed by Health Canada)—met the criteria: that is, a coefficient of variation of < 3% and error criteria 1 of ± 0.85% as specified by the NGSP (in January 2010, the error criteria were lowered to ± 0.75%). ( 14 ) However, since experienced technologists at manufacturers’ sites performed the certification under ideal conditions, the results of this study may not reflect the performance of these devices in clinical settings.

Techniques: Comparison, Selection